Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-11-250474
Filing Date
2011-09-16
Accepted
2011-09-16 16:58:30
Documents
10
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d232612d10k.htm 10-K 2853223
2 STOCK PURCHASE AGREEMENT d232612dex25.htm EX-2.5 554614
3 LETTER AGREEMENT d232612dex106.htm EX-10.6 7944
4 FORM OF NONQUALIFIED STOCK OPTION AGREEMENT (DAVID HEYENS) d232612dex1036.htm EX-10.36 42109
5 STATEMENT REGARDING COMPUTATION OF RATIO OF EARNINGS TO FIXED CHARGES d232612dex121.htm EX-12.1 37371
6 LIST OF SUBSIDIARIES d232612dex211.htm EX-21.1 16687
7 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO RULE 13A-14(A) d232612dex311.htm EX-31.1 6723
8 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO RULE 13A-14(A) d232612dex312.htm EX-31.2 6737
9 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 906 d232612dex321.htm EX-32.1 3069
10 CERTIFICATION OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 906 d232612dex322.htm EX-32.2 3239
  Complete submission text file 0001193125-11-250474.txt   3532701
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent Pharma Solutions, Inc. (Filer) CIK: 0001416083 (see all company filings)

EIN.: 133523163 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 333-147871 | Film No.: 111095782
SIC: 2834 Pharmaceutical Preparations